HOME >> BIOLOGY >> NEWS
UT Southwestern researchers say overdoses of acetaminophen cause most cases of acute liver failure

DALLAS Dec. 17, 2002 Unintentional acetaminophen overdose is the most common cause of acute liver failure in the United States, research from UT Southwestern Medical Center at Dallas shows.

The scientists' findings appear in today's issue of the Annals of Internal Medicine.

"This study is the first to prospectively characterize a large number of patients with acute liver failure," said Dr. William M. Lee, professor of internal medicine at UT Southwestern and the study's principal investigator. "Until recently, only limited data have been available on the causes and outcomes of acute liver failure because of its rarity and a lack of centralized data registry."

Earlier this year, a preliminary report based on the study prompted a Food and Drug Administration advisory committee to recommend stronger warning labels on over-the-counter pain medications and cold-and-cough remedies containing acetaminophen, an analgesic with potency similar to aspirin.

The study found that 39 percent of patients with acute liver failure, a rapidly progressive and frequently fatal disease that annually affects 2,000 people in the United States, were from acetaminophen overdose.

"We observed a much higher frequency of presumed acetaminophen overdose-related hepatotoxicity than previous reports," Lee said. "Unlike in the United Kingdom, more than half of our patients with acetaminophen overdose were believed to have overdosed unintentionally, rather than during a suicide attempt."

Lee said a striking finding of the study was that 73 percent of the patients were women.

"Whether women are innately more susceptible to acute liver failure or are taking more kinds of prescription and nonprescription drugs, and are therefore at a higher risk, remains to be determined," Lee said.

The three-year study looked at 308 patients with acute liver failure from 17 different liver care centers around the country. Lee and his colleagues found th
'"/>

Contact: Susan Morrison
Susan.Morrison@UTSouthwestern.edu
214-648-3404
UT Southwestern Medical Center
16-Dec-2002


Page: 1 2

Related biology news :

1. UT Southwestern receives $1.78 million grant for obesity research as part of NIH Roadmap initiative
2. UT Southwestern biochemist honored with NIH Directors Pioneer Award
3. RSV can increase the risk of asthma, UT Southwestern researchers find
4. Searle Scholars program awards $240,000 to UT Southwestern researcher
5. Two molecules work together to aid transport of immune cells, UT Southwestern researchers find
6. Biochemist becomes 15th UT Southwestern faculty member serving on National Academy of Sciences
7. UT Southwestern researchers reveal mechanisms of smooth-muscle contraction
8. Fetal lungs provide a signal initiating labor, UT Southwestern researchers find
9. UT Southwestern researchers cite recent advances in underlying causes of rare body-fat disorders
10. UT Southwestern researchers discover link that could aid in treatment of kidney cyst diseases
11. UT Southwestern research halts narcolepsy symptoms

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/22/2018)... ... December 21, 2018 , ... ... and hosted the Boston Healthcare Drinks event featuring Helen Chen, Greater China Managing ... China.” , The discussion was moderated by patent attorney David J. Dykeman ...
(Date:12/19/2018)... (PRWEB) , ... December 19, 2018 , ... InTouchMD’s flagship ... innovative products in healthcare for 2018. , PM360 is featuring the recognition in ... products and services offered to the pharmaceutical and medical device industries. , “This ...
(Date:12/18/2018)... ... December 18, 2018 , ... ... cancers and other serious diseases, today announced the publication of an early feasibility ... treatment of rGBM. , The publication of the study, An Early Feasibility ...
Breaking Biology News(10 mins):
(Date:1/7/2019)... ... January 07, 2019 , ... Kainos Medicine Inc. today announced ... candidate, code-named "KM-819." KM-819 is an orally active small molecule that is ... Korea. , This Phase 1 randomized, double-blind, placebo-controlled dose-escalation study was to ...
(Date:12/20/2018)... ... December 20, 2018 , ... New Year’s brings reflection and desire to improve ... the European Union (EU) on the horizon, Jim Kasic, president and CEO of Boulder ... the EU Medical Device Regulation (MDR), digital health, and big data are just a ...
(Date:12/18/2018)... ... ... Patients with early stages of breast cancer who undergo partial breast proton ... irradiation, a new study suggests. , Patients with early stage breast cancer — stage ... the cancerous tumor because there is a 30 to 40 percent change the disease ...
(Date:12/13/2018)... ... December 13, 2018 , ... Microbial Discovery Group LLC (MDG) ... been part of their strategic plan and an important milestone in increasing their ... opportunities for MDG within the $44 Billion human probiotic market. This plan is ...
Breaking Biology Technology:
Cached News: